AI Analysis AI Analysis of CSPCY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CSPCY to Watchlist?
Some Reasons Why To Add CSPCY:
  • Healthy interest coverage ratio of 102.9x
  • Low bankruptcy risk (Altman Z-Score: 7.57)
  • High gross margin of 65.6%
PDF

CSPC Pharmaceutical Group Limited stock downgraded to Hold/Accumulate
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 29, 2026 Loss -2.82%

The CSPC Pharmaceutical Group Limited stock price fell by -2.16% on the last day (Friday, 31st Jul 2026) from $4.40 to $4.31. During the last trading day the stock fluctuated 0% from a day low at $4.31 to a day high of $4.31. The price has been going up and down for this period, and there has been a 5.26% gain for the last 2 weeks. Volume has increased on the last day by 443 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 725 shares were bought and sold for approximately $3.12 thousand.

The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $4.44 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 5.59% during the next 3 months and, with a 90% probability hold a price between $3.60 and $4.69 at the end of this 3-month period.

CSPCY Signals & Forecast

The CSPC Pharmaceutical Group Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.33. On a fall, the stock will find some support from the long-term average at approximately $3.90. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 29, 2026, and so far it has fallen -2.82%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). CSPC Pharmaceutical Group Limited gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for CSPC Pharmaceutical Group Limited stock

CSPC Pharmaceutical Group Limited finds support from accumulated volume at $4.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 0.88%.

Our recommended stop-loss: $4.14 (-3.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (CSPCY) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect CSPC Pharmaceutical Group Limited to open at $4.31, and during the day (based on 14 day Average True Range), to move between $4.26 and $4.35, which gives a possible trading interval of +/-$0.0921 (+/-2.16%) up or down from last closing price. If CSPC Pharmaceutical Group Limited takes out the full calculated possible swing range there will be an estimated 2.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.31 (0.12%) than the support at $4.30 (0.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CSPC Pharmaceutical Group Limited stock A Buy?

CSPC Pharmaceutical Group Limited holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.584 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $4.31 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CSPCY Performance

Trading levels for CSPCY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.31 -
R2 4.31 -
R1 4.31 -
Price 4.31
S1 4.31 -
S2 4.31 -
S3 4.31 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.43 2.90%
R2 4.40 2.21%
R1 4.31 0.116%
Price 4.31
S1 4.30 -0.116%
S2 3.70 -14.05%
S3 3.61 -16.26%

CSPCY Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 25, 2026 Jun 25, 2026 Jul 29, 2026 $0.0614 1.33%
2 Aug 22, 2025 Oct 20, 2025 Dec 03, 2025 $0.0717 1.36%
3 Jun 05, 2025 Jun 05, 2025 Jun 05, 2025 $0 0%
4 Nov 01, 2024 Nov 01, 2024 Dec 05, 2024 $0.0575 2.31%
5 Jun 03, 2024 Jun 03, 2024 Jul 11, 2024 $0.0573 1.84%

FAQ

What is the symbol for CSPC Pharmaceutical Group Limited Stock and on which exchange is it traded?
The symbol for CSPC Pharmaceutical Group Limited is CSPCY and it is traded on the PINK (Pink Sheets).

Should I buy or sell CSPC Pharmaceutical Group Limited Stock?
CSPC Pharmaceutical Group Limited holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy CSPC Pharmaceutical Group Limited Stock?
CSPC Pharmaceutical Group Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CSPC Pharmaceutical Group Limited Stock.

What's the current price of CSPC Pharmaceutical Group Limited Stock?
As of the end of day on the Jul 31, 2026, the price of an CSPC Pharmaceutical Group Limited (CSPCY) share was $4.31.

What is the 52-week high and low for CSPC Pharmaceutical Group Limited Stock?
The 52-week high for CSPC Pharmaceutical Group Limited Stock is $5.83 and the 52-week low is $3.26.

What is the market capitalization of CSPC Pharmaceutical Group Limited Stock?
As of the Jul 31, 2026, the market capitalization of CSPC Pharmaceutical Group Limited is 12.401B.
Click to get the best stock tips daily for free!
ABOUT CSPC PHARMACEUTICAL GROUP LIMITED
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE